• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » J&J struggles to bring Synthes into the fold | MassDevice.com On Call

J&J struggles to bring Synthes into the fold | MassDevice.com On Call

June 10, 2013 By Sony Salzman

MassDevice On Call

MASSDEVICE ON CALL — Michael Orsinger, the J&J executive in charge of the recently formed DePuy Synthes unit, said "less than half of the necessary work" to incorporate Synthes is complete, according to an interview with Swiss business newspaper Finanz und Wirtschaft.

Orsinger noted challenges across the board – from streamlining IT and business platforms to new compliance regulators – but stressed that most of the angst is being felt by the merging companies and not by their customers.

However, he also told Finanzund Wirtschaft that his unit took some losses in their spinal implant business customer base and in thier R&D department. J&J began consildating the 2 companies’ spine business units after purchasing Synthes almost a year ago for a cool $19.7 billion.

 Tattoo removal is big business, with device makers hopping on board

Business is booming for the tattoo removal industry, and Westford, Mass.-based Cynosure (NSDQ:CYNO) is touting an FDA-approved device that pulses light in trillionths of a second and cuts the number of docotr visits in half, according to The Boston Business Journal.  
Read more

 GI tract scopes found with unsanitary "bio-dirt"
A review of hospitals accrosss the States showed that 3 out of 20 GI tract endoscopes had unacceptible levels of "bio-dirt" human cells and other organic material that can pose and infection risk to the next patient.

And GI scopes are not the only cleanliness culprit. The 3M Infection Prevention Division found that 30% of duodenoscopes and 24% of gastroscopes did not pass safety standards, adding to the growing contraversy surrounding cleaning procedures for surgical instruments at U.S. hopsitals, a topic currently up for discussion at the 40th annual Association for Professionals in Infection Control and Epidemiology meeting in Fort Lauderdale, Flor.
Read more

 ex-VA dept. chief says 8 nation-states are sponsoring cyber attacks
The former Chief Information Officer at the Veteran’s Affairs Department said the cyber attacks to the VA network come from 8 nation-state sponsored groups, including the Chinese People’s Liberation Army, according to Nextgov.com. Jerry Davis, who left his position as Chief in February, said attacks continue to this day and that called the VA department the worst he’s seen in terms of cyber security.
Read more

 Former senator Brown criticizes device tax, FDA approval process
Former Mass. Senator Scott Brown spoke out again against the 2.3% excise tax on medical device companies and criticized an the FDA approval process at ACG Boston’s Growth Conference 2013, during an interview with Mergers & Acquisitions. Brown repeated his concern that over-regulation will send device companies abroad and the U.S. will loose its foothold as a powerful leader in innovation.
Read more

Filed Under: Food & Drug Administration (FDA), News Well Tagged With: Cynosure Inc., Johnson and Johnson, On Call

More recent news

  • Johnson & Johnson MedTech launches new Volt plating systems for radius, humerus
  • PharmaSens, SiBionics collab on all-in-one insulin patch pump
  • Beta Bionics to pair iLet automated insulin delivery system with Abbott’s dual glucose-ketone sensor
  • Anaconda Biomed wins CE mark for funnel catheter
  • FDA approves Neuspera neuromod for urinary incontinence

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy